Evidence map›Paper›PMID 38397085›Full record

ArticleInternational journal of molecular sciences2024

ERK1/2-CEBPB Axis-Regulated hBD1 Enhances Anti-Tuberculosis Capacity in Alveolar Type II Epithelial Cells.

Yaoxin Chen, Zhenyu Han, Sian Zhang, Honglin Liu, Ke Wang, Jieyu Liu, Feichang Liu, Shiyun Yu, Na Sai, Haiyan Mai and 4 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Lung epithelial injury impairs early host immune responses to Mycobacterium tuberculosis.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

Yaoxin ChenInstitute of Molecular Immunology, School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou 510515, China.ORCID 0009-0003-9466-4819
Zhenyu HanInstitute of Molecular Immunology, School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou 510515, China.
Sian ZhangInstitute of Molecular Immunology, School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou 510515, China.ORCID 0000-0001-6879-7712
Honglin LiuInstitute of Molecular Immunology, School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou 510515, China.ORCID 0000-0001-8136-4014
Ke WangInstitute of Molecular Immunology, School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou 510515, China.
Jieyu LiuInstitute of Molecular Immunology, School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou 510515, China.
Feichang LiuInstitute of Molecular Immunology, School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou 510515, China.
Shiyun YuInstitute of Molecular Immunology, School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou 510515, China.
Na SaiInstitute of Molecular Immunology, School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou 510515, China.
Haiyan MaiInstitute of Molecular Immunology, School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou 510515, China.
Xinying ZhouInstitute of Molecular Immunology, School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou 510515, China.
Chaoying ZhouInstitute of Molecular Immunology, School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou 510515, China.
Qian WenInstitute of Molecular Immunology, School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou 510515, China.ORCID 0000-0001-5935-6237
Li MaInstitute of Molecular Immunology, School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou 510515, China.
Southern Medical University · CN

Funding

Guangdong Basic and Applied Basic Research Foundation 2020A1515010019Guangdong Basic and Applied Basic Research Foundation 2021A1515011082National key research and development program of China 2022YFA1303501National Natural Science Foundation of China 82072242National Natural Science Foundation of China 82272344Provincial key laboratory of immune regulation and immunotherapy 2022B1212010009Science and Technology Projects in Guangzhou 202201010837
6 · The paper itself

Abstract

Tuberculosis, caused by

Indexed as

beta-DefensinsMycobacterium tuberculosisTuberculosisAlveolar Epithelial CellsAnimalsCCAAT-Enhancer-Binding Protein-betaEpithelial CellsHumansMAP Kinase Signaling SystemMicebeta-DefensinsCCAAT-Enhancer-Binding Protein-betaCEBPB protein, humanalveolar type II epithelial cellsCEBPBhuman β-defensin 1Mycobacterium tuberculosis

Identifiers

PMID38397085
PMCPMC10889425
OpenAlexW4391931477

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.